Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × enasidenib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 14 Leukemia, Myelomonocytic, Chronic 3 Myelodysplastic Syndromes 2 Leukemia 2 Sinonasal undifferentiated carcinoma 1 Neoplasms 1 Myeloproliferative Disorders 1 Lymphoma, T-Cell 1 Leukemia, Myeloid 1 Leukemia, Biphenotypic, Acute 1 Esthesioneuroblastoma, Olfactory 1 Clonal Cytopenia of Undetermined Significance 1 Chondrosarcoma 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡